Biocon Waits On FDA Insulin Inspection

Indian Company Seeks US Agency Stance On Mutual Recognition Agreement Route

 
• By Anju Ghangurde
Firms Await Regulatory Inspections
Indian Firms Face Limited Visibility In Inspection Schedules • Source: Alamy

More from Biosimilars

More from Products